Genzyme
FABRAZYME
Manufacturer:
Genzyme
Name:
FABRAZYME
HCPCS Code Descriptor:
Injection, agalsidase beta, 1 mg
Category:
J Code
HCPCS:
J0180
NDC(s):
58468-0040-01, 58468-0041-01
Primary Type:
Enzyme Replacement Therapy
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
FABRAZYME is an Enzyme Replacement Therapy drug manufactured by Genzyme and administered via the Intravenous route of administration. The J Code: J0180 is aligned to the drug FABRAZYME.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/05
HCPCS Effective Date:
1/1/05
HCPCS Short Description:
Agalsidase beta injection
Billing and Coding Guide:
https://hcp.fabrazyme.com/dam/jcr:65ffd5e5-e29a-4207-b6e6-5affeed5528a/Fabrazyme_Reimbursement_Billing_GuideMAT-US-2017018Aug2021.pdf
Patient Assistance:
Not Found